688192.XSHG Overview
Upcoming Projects (688192.XSHG)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (688192.XSHG)
-
Looking at the FDA approval of Dizal's ZEGFROVY® (sunvozertinib) for NSCLC patients with EGFR exon 20 insertions after platinum-based chemotherapy
Tickers: 688192.XSHG, CGEM
Executed On: Jul 30, 2025 at 01:30 PM EDT
Upcoming & Overdue Catalysts (688192.XSHG)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (688192.XSHG)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
